• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】18684

【品名】6,7-dimethoxy-4(3H)-quinazolinone

【CA登记号】13794-72-4

【 分 子 式 】C10H10N2O3

【 分 子 量 】206.20108

【元素组成】C 58.25% H 4.89% N 13.59% O 23.28%

与该中间体有关的原料药合成路线共 6 条

合成路线1

该中间体在本合成路线中的序号:(I)

Monodemethylation of 6,7-dimethoxyquinazolin-4(3H)-one (I) in refluxing methanesulfonic acid in the presence of L-methionine provides 6-hydroxy-7-methoxyquinazolin-4(3H)-one (II), which is acetylated with acetic anhydride and pyridine at 100 C to give the acetate (III). Treatment of compound (III) with refluxing SOCl2 and a catalytic amount of DMF yields chloride (IV), which by condensation with 3-chloro-4-fluoroaniline (V) in boiling isopropanol affords the anilinoquinazoline (VI). Hydrolysis of the acetate group of (VI) by treatment with NH4OH in refluxing MeOH gives the 6-hydroxyquinazoline derivative (VII), which finally is alkylated with 3-(4-morpholinyl)-propyl chloride (VIII) or 3-(4-morpholinyl)propyl bromide (IX).

1 Gibson, K.H.; Grundy, W.; Barker, A.J.; et al.; Studies leading to the identification of ZD1839 (Iressa(TM)): An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg Med Chem Lett 2001, 11, 14, 1911.
2 D'Souza, N.; Castañer, J.; Levin, M.; Iressa. Drugs Fut 2002, 27, 4, 339.
3 Gibson, K.H. (AstraZeneca plc); Quinazoline derivs.. EP 0823900; JP 1999504033; US 5770599; WO 9633980 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18684 6,7-dimethoxy-4(3H)-quinazolinone 13794-72-4 C10H10N2O3 详情 详情
(II) 18685 6-hydroxy-7-methoxy-4(3H)-quinazolinone 179688-52-9 C9H8N2O3 详情 详情
(III) 18686 7-methoxy-4-oxo-3,4-dihydro-6-quinazolinyl acetate 179688-53-0 C11H10N2O4 详情 详情
(IV) 18687 4-chloro-7-methoxy-6-quinazolinyl acetate 230955-75-6 C11H9ClN2O3 详情 详情
(V) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(VI) 18689 4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinyl acetate 788136-89-0 C17H13ClFN3O3 详情 详情
(VII) 18690 4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinol 184475-71-6 C15H11ClFN3O2 详情 详情
(VIII) 18691 4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine 7357-67-7 C7H14ClNO 详情 详情
(IX) 52653 4-(3-bromopropyl)morpholine 125422-83-5 C7H14BrNO 详情 详情

合成路线2

该中间体在本合成路线中的序号:(V)

4,5-Dimethoxy-2-nitrobenzoic acid (I) was treated with thionyl chloride to form acid chloride (II), followed by reaction with ammonia to yield 4,5-dimethoxy-2-nitrobenzamide (III). This was reduced with sodium borohydride in the presence of copper sulfate to give aminobenzamide (IV), which was refluxed with formic acid to afford 6,7-dimethoxyquinazoline-4(3H)-one (V). Subsequent treatment of (V) with phosphoryl chloride gave the chloroquinazoline (VI). The title compound was then prepared by condensation of (VI) with 2-bromo-4-aminophenol (VII) in refluxing ethanol.

1 Liu, X.-P.; Narla, R.K.; Uckun, F.M. (Parker Hughes Institute); Quinazolines for treating brain tumor. WO 9961428 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 31789 4,5-dimethoxy-2-nitrobenzoic acid 4998-07-6 C9H9NO6 详情 详情
(II) 31790 4,5-dimethoxy-2-nitrobenzoyl chloride C9H8ClNO5 详情 详情
(III) 31791 4,5-dimethoxy-2-nitrobenzamide 4959-60-8 C9H10N2O5 详情 详情
(IV) 31792 2-amino-4,5-dimethoxybenzamide 5004-88-6 C9H12N2O3 详情 详情
(V) 18684 6,7-dimethoxy-4(3H)-quinazolinone 13794-72-4 C10H10N2O3 详情 详情
(VI) 23765 4-chloro-6,7-dimethoxyquinazoline; 4-chloro-6-methoxy-7-quinazolinyl methyl ether C10H9ClN2O2 详情 详情
(VII) 31793 4-amino-2-bromophenol C6H6BrNO 详情 详情

合成路线3

该中间体在本合成路线中的序号:(V)

4,5-Dimethoxy-2-nitrobenzoic acid (I) was treated with thionyl chloride to form acid chloride (II), followed by reaction with ammonia to yield 4,5-dimethoxy-2-nitrobenzamide (III). This was reduced with sodium borohydride in the presence of copper sulfate to give aminobenzamide (IV), which was refluxed with formic acid to afford 6,7-dimethoxyquinazoline-4(3H)-one (V). Subsequent treatment of (V) with phosphoryl chloride gave the chloroquinazoline (VI). The title compound was then prepared by condensation of (VI) with 4-aminophenol (VII) in refluxing ethanol.

1 Liu, X.-P.; Narla, R.K.; Uckun, F.M. (Parker Hughes Institute); Quinazolines for treating brain tumor. WO 9961428 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 31789 4,5-dimethoxy-2-nitrobenzoic acid 4998-07-6 C9H9NO6 详情 详情
(II) 31790 4,5-dimethoxy-2-nitrobenzoyl chloride C9H8ClNO5 详情 详情
(III) 31791 4,5-dimethoxy-2-nitrobenzamide 4959-60-8 C9H10N2O5 详情 详情
(IV) 31792 2-amino-4,5-dimethoxybenzamide 5004-88-6 C9H12N2O3 详情 详情
(V) 18684 6,7-dimethoxy-4(3H)-quinazolinone 13794-72-4 C10H10N2O3 详情 详情
(VI) 23765 4-chloro-6,7-dimethoxyquinazoline; 4-chloro-6-methoxy-7-quinazolinyl methyl ether C10H9ClN2O2 详情 详情
(VII) 15715 4-Aminophenol 123-30-8 C6H7NO 详情 详情

合成路线4

该中间体在本合成路线中的序号:(II)

6,7-Dimethoxy-4-quinazolone (II) was prepared by condensation of methyl 4,5-dimethoxyanthranilate (I) with formamide at 160 C. Chlorination of (II) by means of phosphorus oxychloride provided the 4-chloro quinazoline (III). Substitution of the 4-chloro group of (III) by the sodium salt of 4-amino-3-chlorophenol (IV) gave rise to the quinazolinyl ether (V). Finally, condensation of amine (V) with triphosgene, followed by addition of n-propylamine furnished the title urea derivative.

1 Kubo, K.; Iwakubo, M.; Fujiwara, Y.; et al.; Synthesis and structure-activity relationship of quinazoline-urea derivatives as novel orally active VEGF tyrosine kinase selective inhibitors. Proc Am Assoc Cancer Res 2002, 43, Abst 913.
2 Kubo, K.; Fujiwara, Y.; Isoe, T. (Kirin Brewery Co., Ltd.); Quinoline derivs. and quinazoline derivs.. EP 1153920; WO 0043366 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 54810 2-Amino-4,5-dimethoxybenzoic acid methyl ester; Methyl 2-amino-4,5-dimethoxybenzoate; Methyl 4,5-dimethoxyanthranilate 26759-46-6 C10H13NO4 详情 详情
(II) 18684 6,7-dimethoxy-4(3H)-quinazolinone 13794-72-4 C10H10N2O3 详情 详情
(III) 23765 4-chloro-6,7-dimethoxyquinazoline; 4-chloro-6-methoxy-7-quinazolinyl methyl ether C10H9ClN2O2 详情 详情
(IV) 54811 4-amino-3-chlorophenol C6H6ClNO 详情 详情
(V) 54812 2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]aniline; 2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenylamine C16H14ClN3O3 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

 

1 Jyothi Prasad R,Nageshwar Rao B,et al. 2007. A novel prcess for preparation of erlotinib. WO 2007060691
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18684 6,7-dimethoxy-4(3H)-quinazolinone 13794-72-4 C10H10N2O3 详情 详情
(II) 66356 6,7-dihydroxyquinazolin-4(3H)-one   C8H6N2O3 详情 详情
(III) 66357 4-oxo-3,4-dihydroquinazoline-6,7-diyl diacetate   C12H10N2O5 详情 详情
(IV) 66358 4-chloroquinazoline-6,7-diyl diacetate   C12H9ClN2O4 详情 详情
(V) 66359 4-((3-ethynylphenyl)amino)quinazoline-6,7-diyl diacetate   C20H15N3O4 详情 详情
(VI) 66360 4-((3-ethynylphenyl)amino)quinazoline-6,7-diol   C16H11N3O2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(XIII)

Chlorination of 4,5-dimethoxy-2-nitrobenzoic acid (X) with SOCl2, followed by reaction with aqueous ammonia yields the nitrobenzamide (XI), which is reduced to the corresponding aminobenzamide (XII) by means of NaBH4 in the presence of catalytic amounts of CuSO4. Anthranilamide (XII) is then cyclized to quinazolinone (XIII) by refluxing in formic acid . Alternatively, cyclization of 4,5-dimethoxyanthranilic acid (XIV), either by heating with formamide at 190 °C or with formamidine hydrochloride at 210 °C , gives rise to quinazolinone (XIII) . Subsequent chlorination of compound (XIII) to the corresponding 4-chloroquinazoline (XV) is accomplished by treatment with either POCl3 , SOCl2 or (COCl)2 in the presence of catalytic amounts of DMF. Chloroquinazoline (XV) is then condensed with 3-bromoaniline (VIII) in refluxing EtOH or i-PrOH to produce anilinoquinazoline (XVI) , which is finally demethylated by either treatment with BBr3 in THF or by heating with pyridinium chloride at 205 °C .

1 Hu, S., Xie, G., Zhang, D.X. et al. Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors. Bioorg Med Chem Lett 2012, 22(19): 6301-5.
2 Uckun, F.M., Narla, R.K., Liu, X.-P. (Parker Hughes Institute). Quinazolines for treating brain tumor. EP 1082311, JP 2002516823, US 6316454, WO 1999061428.
3 Barker, A.J. (AstraZeneca plc). Quinazoline derivatives. CA 2086968, EP 0566226, JP 1994073025, US 5457105, US 5616582.
4 Johnström, P., Fredriksson, A., Thorell, J.-O., Stone-Elander, S. Synthesis of [methoxy-11C]PD153035, a selective EGR receptor tyrosine kinase inhibitor. J Label Compd Radiopharm 1998, 41(7): 623-9.
5 Bridges, A.J., Zhou, H., Cody, D.R. et al. Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. J Med Chem 1996, 39(1): 267-76.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 67978 4-[(3-bromophenyl)amino]-6,7-dihydroxyquinazoline   C14H10BrN3O2 详情 详情
(VIII) 19136 3-bromoaniline; 3-bromophenylamine; 3-bromobenzenamine 591-19-5 C6H6BrN 详情 详情
(X) 31789 4,5-dimethoxy-2-nitrobenzoic acid 4998-07-6 C9H9NO6 详情 详情
(XI) 31791 4,5-dimethoxy-2-nitrobenzamide 4959-60-8 C9H10N2O5 详情 详情
(XII) 31792 2-amino-4,5-dimethoxybenzamide 5004-88-6 C9H12N2O3 详情 详情
(XIII) 18684 6,7-dimethoxy-4(3H)-quinazolinone 13794-72-4 C10H10N2O3 详情 详情
(XIV) 23763 2-amino-4,5-dimethoxybenzoic acid 5653-40-7 C9H11NO4 详情 详情
(XV) 23765 4-chloro-6,7-dimethoxyquinazoline; 4-chloro-6-methoxy-7-quinazolinyl methyl ether C10H9ClN2O2 详情 详情
(XVI) 67984 N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride 183322-45-4 C16H14BrN3O2.HCl 详情 详情
Extended Information